Assessment of the Pricing Policy on the Pharma Sector

Assisted the Jordanian Association of Pharmaceutical Manufacturers (JAPM) in understanding the legal framework of the pricing regulation; reviewing the current pricing policy/practices and assessing its impact on the sector’s profitability and competitiveness; assessing the impact of current pricing policy/practices on the Jordanian economy; reviewing the implications of having higher prices for imported generics vs. local generics; reviewing the current price increase approval process and recommending an improved institutionalized mechanism for price increase requests as required. This was followed by detailed reporting on the current situation regarding pricing, and data collected on (10) products for further economic analysis, report on current prices policies, and regional legal systems.